Skip to main content
. 2022 Mar 15;12:836504. doi: 10.3389/fonc.2022.836504

Table 2.

Summary of historical analyses of hearing loss vs. imaging characteristics in patients with vestibular schwannoma.

Reference Size Technique N Imaging Sequence Impaction Tumor Characteristics Outcome
Significant Not significant
Berrettini et al. (30)
  • MLD

42 MRI+ T1 IAC extent
  • Sporadic, unilateral

  • Evaluation at initial presentation

  • No significant difference of HL between different sized tumors.

  • No significant correlation of tumor origin and subjective HL.

Nadol et al. (31)
  • MLD

  • IAC extent

75 MRI+ T1 IAC extent
  • Sporadic, unilateral

  • Preoperative evaluation

  • Significant correlation between MLD and low-frequency SNHL severity.

  • No significant correlations between MLD and SNHL severity in high/mid-frequencies or SDSs, and lateral extent of the tumor within the IAC and SDSs.

Lalwani et al. (32)
  • Tumor volume

  • Linear dimensions

40 MRI
  • NF2

  • Evaluation at initial presentation

  • PTA significantly worse in the “larger tumor” groups.

  • Worsening SRT with larger tumor size (TV dimension, volume).

  • PTAs for individual frequencies were not correlated with tumor size.

Tanaka et al. (33)
  • MLD

34 MRI
  • Sporadic, unilateral

  • Diagnostic intervention

  • No significant correlation between the detective threshold of compound action potential or cochlear microphonics (ECochG) and tumor size.

Massick et al. (34)
  • MLD

  • Tumor volume

21 MRI+ T1
  • Sporadic, unilateral

  • NF2

  • Sequential follow-up

  • Increasing TV correlates with HL (increased PTA, decreased WRS).

  • Decline of initial auditory function class corresponds with an even quicker rate of audiometric decline with tumor growth.

Tschudi et al. (35)
  • MLD

74 MRI
  • Sporadic, unilateral

  • Evaluation at initial presentation

  • Sequential follow-up

  • Higher-frequency thresholds were more impacted than lower frequencies, but no significant correlation between tumor size and initial HL.

  • No significant correlation between tumor growth and HL.

Wang et al. (36)
  • MLD

7 MRI
  • NF2

  • Diagnostic intervention

  • No significant relationship between tumor size and hearing level.

Caye-Thomasen et al. (15)
  • Tumor volume

  • Localization

156 MRI- T2 IAC extent
  • Sporadic, unilateral

  • Intracanalicular

  • Evaluation at initial presentation

  • Sequential follow-up

  • Significant correlation between absolute volumetric tumor growth rate and PTA deterioration rate.

  • HL diagnosis at time of presentation is irrespective of patient demographics, tumor sublocalization, and tumor-induced expansion of the IAC.

Day et al. (37)
  • MLD

44 MRI T1
MRI T2
MRI Proton density
IAC extent
  • Sporadic, unilateral

  • Diagnostic intervention

  • Significant trend of correlation with tumor size and HL.

Fisher et al. (38)
  • MLD

52 MRI+ T1
MRI T2
  • NF2

  • Sequential follow-up

  • No significant association between VS size hearing for either side.

  • No significant relation between change in tumor size and hearing deterioration.

Gerganov et al. (39)
  • MLD

  • Tumor volume

99 MRI- T1
MRI- T2
MRI+ T1
MRI+ T2
  • IAC extent

  • Tumor-fundus distance

  • Sporadic, unilateral

  • Preoperative evaluation

  • Hearing ability correlated significantly with the tumor size, volume and coronal diameter, the degree of intrameatal tumor growth, and the distance between tumor end and fundus.

Sughrue et al. (40)
  • Localization

59 MRI
  • Sporadic, unilateral

  • NF2, unilateral

  • Evaluation at initial presentation

  • Sequential follow-up

  • Hearing is lost at a quicker rate in faster-growing tumors than slow-growing tumors.

  • Initial tumor size at diagnosis did not significantly affect the time to serviceable HL.

Van de Langenberg et al. (12)
  • Tumor volume

63 MRI+ T1
MRI- T2
  • Sporadic

  • Evaluation at initial presentation

  • Sequential follow-up

  • Labyrinthine hypo-intensity (T2) and HL complaints at presentation predictive of faster hearing decline.

  • TV and change in TV does not correlate significantly with HL.

Asthagiri et al. (41)
  • Tumor volume

56 MRI- T1
MRI- FLAIR
MRI+ T1
Co-registered T2-VISTA
MRI+ delayed FLAIR
Cochlear aperture obstruction
  • NF2

  • Diagnostic intervention

  • Association between HL and tumor size (TV) is not strong enough.

  • HL appears to possibly develop from cochlear aperture obstruction and intralabyrinthine protein accumulation.

Tutar et al. (42)
  • MLD (extrameatal)

76 MRI
  • Sporadic, unilateral

  • Preoperative evaluation

  • No correlation found between tumor size and hearing levels at each frequency.

Holliday et al. (9)
  • Tumor volume

32 MRI+ T1
MRI- T2 TSE VISTA
MRI- FLAIR
Cochlear aperture obstruction
  • NF2

  • Diagnostic intervention

  • Elevated intralabyrinthine protein correlated with larger tumors.

  • Significant association between aperture obstruction and 4-tone PTA and ABR changes.

  • Tumor volume was not significantly correlated with 4-tone PTA.

Plotkin et al. (43)
  • Tumor volume

120 MRI+ T1
  • NF2

  • Sequential follow-up

  • Significant difference in time to hearing decline with medium/large tumors having a shorter median time to hearing decline compared with small tumors.

Van Linge et al. (44)
  • Tokyo consensus

  • Localization

155 MRI+ T1
MRI- T2 FIESTA
MRI- T2 CISS
  • Sporadic, unilateral

  • Sequential follow-up

  • Tumor growth associated with faster AHDR for intracanalicular tumors.

  • PTA or SDS in the ipsilateral ear did not differ between classes of intensity of the cochlear fluid signal.

Kirchmann et al. (13)
  • MLD

  • Localization

156 MRI
  • Sporadic, unilateral

  • Sequential follow-up

  • Hearing is lost at a significantly faster rate in growing tumors.

  • Rate of SDS decrease is not significantly associated with tumor growth.

  • No significant difference between HL progression in patients with intrameatal versus extrameatal tumors.

West et al. (45)
  • MLD (extrameatal)

124 MRI
  • Sporadic, unilateral

  • Extrameatal

  • Preoperative evaluation

  • Caloric tests and VEMPs are potential clinical factors for measuring tumor size, sensitive but remain unspecific.

  • No correlation between increasing tumor size and HL and peripheral vestibular function.

Byun et al. (14)
  • MLD

  • Localization

23 MRI+ T1
MRI- T2
  • Sporadic, unilateral

  • Evaluation at initial presentation

  • Intracanalicular tumors associated with increased DRs than extracanalicular tumors.

  • No strong correlation between tumor size and WRS/PTA.

  • No significant correlation with PTA and T2-weighted signal intensity.

Early et al. (16)
  • MLD

534 MRI
  • Sporadic, unilateral

  • NF2

  • Evaluation at initial presentation

  • Sequential follow-up

  • Patients with abnormal baseline hearing of the ipsilateral ear, demonstrated significantly higher likelihood of reaching moderate SNHL in the contralateral ear.

  • Patients with normal baseline hearing bilaterally demonstrated no significant difference in HL progression in VS-contralateral vs. control ears.

  • Subgroup analysis by baseline tumor size did not show any specific trends for HL progression.

Selleck et al. (11)
  • MLD

  • Cochlear FLAIR ratio

393 MRI- T2 FLAIR
MRI- T2 CISS
Fundal cap size
  • Sporadic, unilateral

  • Evaluation at initial presentation

  • An indirect, significant relationship exists between initial WRS and cochlear FLAIR ratio.

  • Significant correlation was seen between decreasing WRSs and increasing fundal cap size.

  • No statistically significant correlation between initial PTA and cochlear FLAIR ratio.

  • No statistically significant correlation between initial WRS and PTA, and fundal cap.